Pages that link to "Q46440075"
Jump to navigation
Jump to search
The following pages link to Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice (Q46440075):
Displaying 27 items.
- Methamphetamine toxicity and messengers of death (Q24647617) (← links)
- Parallel manifestations of neuropathologies in the enteric and central nervous systems (Q26823182) (← links)
- The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease (Q28068464) (← links)
- Vacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease (Q28074841) (← links)
- Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease (Q33323265) (← links)
- Protective effect of alpha-synuclein knockdown on methamphetamine-induced neurotoxicity in dopaminergic neurons (Q34095954) (← links)
- Amphetamine toxicities: classical and emerging mechanisms. (Q34102002) (← links)
- 3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects (Q34365007) (← links)
- A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease (Q34571131) (← links)
- Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice (Q35000199) (← links)
- Overexpression of alpha-synuclein following methamphetamine: is it good or bad? (Q36653961) (← links)
- Neurotoxins and neurotoxicity mechanisms. An overview. (Q36696105) (← links)
- Targeting the progression of Parkinson's disease. (Q37299619) (← links)
- Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys (Q37350181) (← links)
- Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors (Q39153958) (← links)
- Escalating Methamphetamine Regimen Induces Compensatory Mechanisms, Mitochondrial Biogenesis, and GDNF Expression, in Substantia Nigra (Q39175231) (← links)
- Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review. (Q39356354) (← links)
- Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability (Q39692786) (← links)
- D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice (Q40227540) (← links)
- Lack of involvement of alpha-synuclein in unconditioned anxiety in mice (Q41881379) (← links)
- Deletion of alpha-synuclein decreases impulsivity in mice. (Q42151730) (← links)
- 3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity (Q43543985) (← links)
- Alpha-synuclein deletion decreases motor impulsivity but does not affect risky decision making in a mouse Gambling Task. (Q46949239) (← links)
- In PC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition (Q48370032) (← links)
- Melatonin reduces the expression of alpha‐synuclein in the dopamine containing neuronal regions of amphetamine‐treated postnatal rats (Q48944269) (← links)
- Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment. (Q55396058) (← links)
- Alpha-synuclein and heroin craving in opiate-dependent patients on injectable heroin maintenance (Q57780022) (← links)